| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |